A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial (Q28187137)
Jump to navigation
Jump to search
scientific article (publication date: August 2001)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial |
scientific article (publication date: August 2001) |
Statements
A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial (English)
0 references
August 2001
0 references
142
0 references
2
0 references
244-7
0 references